Protein Inhibitor of Activated Signal Transducer and Activator of Transcription 1 Interacts with the N-Terminal Domain of Mineralocorticoid Receptor and Represses Its Transcriptional Activity: Implication of Small Ubiquitin-Related Modifier 1 Modification

Molecular Endocrinology

Volumn 17, Issue 12, 2003, Pages 2529-2542

  Tallec, Laurent Pascual Le ^a   Kirsh, Olivier ^c   Lecomte, Marie Christine ^b   Viengchareun, Say ^a   Zennaro, Maria Christina ^a   Dejean, Anne ^c   Lombès, Marc ^a,b  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; GLUCOCORTICOID RECEPTOR; GLUTATHIONE TRANSFERASE; LIGAND; LIGASE; LYSINE; MINERALOCORTICOID RECEPTOR; PROTEIN INHIBITOR; STAT1 PROTEIN; SUMO 1 PROTEIN;

AGONIST; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CONJUGATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DRUG ANTAGONISM; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MOLECULAR MECHANICS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSACTIVATION; TWO HYBRID SYSTEM; YEAST;

BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; HELA CELLS; HUMANS; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEINS; RECEPTORS, MINERALOCORTICOID; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION, GENETIC; TRANSFECTION; UBIQUITIN;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MURINAE; ONCOVIRINAE;

EID: 0348110369     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0299     Document Type: Article

References (60)

1. Nuclear Receptor Nomenclature Committee 1999 A unified nomenclature system for the nuclear receptor superfamily. Cell 97:161-163
2. Bonvalet JP 1998 Regulation of sodium transport by steroid hormones. Kidney Int Suppl 65:S49-S56
3. Arriza JL, Simerly RB, Swanson LW, Evans RM 1988 The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1:887-900
4. Lombes M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP 1995 Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart. Circulation 92:175-182
5. Funder JW, Pearce PT, Smith R, Smith AI 1988 Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583-585
6. Farman N, Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280:F181-F192
7. Lombes M, Kenouch S, Souque A, Farman N, Rafestin-Oblin ME 1994 The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology 135:834-840
8. Couette B, Fagart J, Jalaguier S, Lombes M, Souque A, Rafestin-Oblin ME 1996 Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure. Biochem J 315: 421-427
9. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
10. Zennaro MC, Keightley MC, Kotelevtsev Y, Conway GS, Soubrier F, Fuller PJ 1995 Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. J Biol Chem 270:21016-21020
11. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
12. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW 1999 Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69:3-12
13. Heery DM, Kalkhoven E, Hoare S, Parker MG 1997 A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-736
14. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675
15. Hong H, Kohli K, Garabedian MJ, Stallcup MR 1997 GRIP1, a transcriptional coactivator for the AF-2 trans-activation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-2744
16. Ding XF, Anderson CM, Ma H, Hong H, Uht RM, Kushner PJ, Stallcup MR 1998 Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol 12:302-313
17. Hittelman AB, Burakov D, Iniguez-Lluhi JA, Freedman LP, Garabedian MJ 1999 Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J 18:5380-5388
18. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ, O'Malley BW 1999 A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97:17-27
19. Yang L, Guerrero J, Hong H, DeFranco DB, Stallcup MR 2000 Interaction of the τ2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol Biol Cell 11: 2007-2018
20. Hellal-Levy C, Fagart J, Souque A, Wurtz JM, Moras D, Rafestin-Oblin ME 2000 Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor. Mol Endocrinol 14:1210-1221
21. Zennaro MC, Souque A, Viengchareun S, Poisson E, Lombes M 2001 A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol Endocrinol 15:1586-1598
22. Fuse H, Kitagawa H, Kato S 2000 Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Mol Endocrinol 14:889-899
23. Kitagawa H, Yanagisawa J, Fuse H, Ogawa S, Yogiashi Y, Okuno A, Nagasawa H, Nakajima T, Matsumoto T, Kato S 2002 Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Mol Cell Biol 22:3698-3706
24. Jackson PK 2001 A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev 15:3053-3058
25. Govindan MV, Warriar N 1998 Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. J Biol Chem 273:24439-24447
26. Hu X, Lazar MA 1999 The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402:93-96
27. Iniguez-Lluhi JA, Pearce D 2000 A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol Cell Biol 20:6040-6050
28. Desterro JM, Thomson J, Hay RT 1997 Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett 417:297-300
29. Hollenberg SM, Evans RM 1988 Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55:899-906
30. Hovland AR, Powell RL, Takimoto GS, Tung L, Horwitz KB 1998 An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem 273:5455-5460
31. Jenster G, van der Korput HA, Trapman J, Brinkmann AO 1995 Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 270:7341-7346
32. Chamberlain NL, Whitacre DC, Miesfeld RL 1996 Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J Biol Chem 271:26772-26778
33. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K 1998 Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci USA 95:10626-10631
34. Tan J, Hall SH, Hamil KG, Grossman G, Petrusz P, Liao J, Shuai K, French FS 2000 Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor co-regulator expressed in human testis. Mol Endocrinol 14:14-26
35. Moilanen AM, Karvonen U, Poukka H, Yan W, Toppari J, Janne OA, Palvimo JJ 1999 A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J Biol Chem 274:3700-3704
36. Kotaja N, Aittomaki S, Silvennoinen O, Palvimo JJ, Janne OA 2000 ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol Endocrinol 14: 1986-2000
37. Tan JA, Hall SH, Hamil KG, Grossman G, Petrusz P, French FS 2002 Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators. J Biol Chem 277:16993-17001
38. Fagart J, Wurtz JM, Souque A, Hellal-Levy C, Moras D, Rafestin-Oblin ME 1998 Antagonism in the human mineralocorticoid receptor. EMBO J 17:3317-3325
39. Kumar R, Thompson EB 2003 Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. Mol Endocrinol 17:1-10
40. Rogerson FM, Fuller PJ 2003 Interdomain interactions in the mineralocorticoid receptor. Mol Cell Endocrinol 200: 45-55
41. He B, Kemppainen JA, Wilson EM 2000 FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275:22986-22994
42. Thompson J, Saatcioglu F, Janne OA, Palvimo JJ 2001 Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol Endocrinol 15:923-935
43. Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL, Baxter JD, Kushner PJ 2000 The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol 14:1976-1985
44. Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE, Hollenberg AN 2001 The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol Endocrinol 15:1049-1061
45. Makowski A, Brzostek S, Cohen RN, Hollenberg AN 2003 Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor. Mol Endocrinol 17:273-286
46. Kahyo T, Nishida T, Yasuda H 2001 Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell 8:713-718
47. Schmidt D, Muller S 2002 Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci USA 99:2872-2877
48. Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R 2001 PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev 15:3088-3103
49. Seeler JS, Marchio A, Losson R, Desterro JM, Hay RT, Chambon P, Dejean A 2001 Common properties of nuclear body protein SP100 and TIF1α chromatin factor: role of SUMO modification. Mol Cell Biol 21:3314-3324
50. Jimenez-Lara AM, Heine MJ, Gronemeyer H 2002 PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2. FEBS Lett 526:142-146
51. Kotaja N, Karvonen U, Janne OA, Palvimo JJ 2002 The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem 277:30283-30288
52. Poukka H, Karvonen U, Janne OA, Palvimo JJ 2000 Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci USA 97:14145-14150
53. Liu W, Wang J, Yu G, Pearce D 1996 Steroid receptor transcriptional synergy is potentiated by disruption of the DNA-binding domain dimer interface. Mol Endocrinol 10: 1399-1406
54. Lombes M, Binart N, Oblin ME, Joulin V, Baulieu EE 1993 Characterization of the interaction of the human mineralocorticosteroid receptor with hormone response elements. Biochem J 292:577-583
55. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275
56. Deppe CE, Heering PJ, Viengchareun S, Grabensee B, Farman N, Lombes M 2002 Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology 143:1932-1941
57. Nicolas G, Fournier CM, Galand C, Malbert-Colas L, Bournier O, Kroviarski Y, Bourgeois M, Camonis JH, Dhermy D, Grandchamp B, Lecomte MC 2002 Tyrosine phosphorylation regulates α II spectrin cleavage by calpain. Mol Cell Biol 22:3527-3536
58. Vandewalle A, Lelongt B, Geniteau-Legendre M, Baudouin B, Antoine M, Estrade S, Chatelet F, Verroust P, Cassingena R, Ronco P 1989 Maintenance of proximal and distal cell functions in SV40-transformed tubular cell lines derived from rabbit kidney cortex. J Cell Physiol 141:203-221
59. Prie D, Friedlander G, Coureau C, Vandewalle A, Cassingena R, Ronco PM 1995 Role of adenosine on glucagon-induced cAMP in a human cortical collecting duct cell line. Kidney Int 47:1310-1318
60. Zennaro MC, Le Menuet D, Lombes M 1996 Characterization of the human mineralocorticoid receptor gene 5′-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms. Mol Endocrinol 10:1549-1560